BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Farmers Insurance
Cerilliant
Covington
Accenture
Dow
Johnson and Johnson
Citi
McKesson
Fuji

Generated: January 18, 2018

DrugPatentWatch Database Preview

Thiotepa - Generic Drug Details

« Back to Dashboard

Pharmacology for thiotepa
Drug ClassAlkylating Drug
Mechanism of ActionAlkylating Activity
Medical Subject Heading (MeSH) Categories for thiotepa

US Patents and Regulatory Information for thiotepa

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Immunex THIOTEPA thiotepa INJECTABLE;INJECTION 011683-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Parenteral THIOTEPA thiotepa INJECTABLE;INJECTION 075730-001 Apr 20, 2001 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Immunex THIOPLEX thiotepa INJECTABLE;INJECTION 020058-001 Dec 22, 1994 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Adienne Sa TEPADINA thiotepa POWDER;IV (INFUSION) 208264-001 Jan 26, 2017 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Adienne Sa TEPADINA thiotepa POWDER;IV (INFUSION) 208264-002 Jan 26, 2017 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Adienne Sa TEPADINA thiotepa POWDER;IV (INFUSION) 208264-001 Jan 26, 2017 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fresenius Kabi Usa THIOTEPA thiotepa INJECTABLE;INJECTION 075698-001 Sep 20, 2001 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int THIOTEPA thiotepa INJECTABLE;INJECTION 075547-001 Apr 2, 2001 RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Parenteral THIOTEPA thiotepa INJECTABLE;INJECTION 075730-002 Apr 20, 2001 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Adienne Sa TEPADINA thiotepa POWDER;IV (INFUSION) 208264-002 Jan 26, 2017 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Argus Health
Federal Trade Commission
McKinsey
Novartis
Farmers Insurance
Queensland Health
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot